Paul Polakis

Molecular Biology · 2000–2016

A researcher in the Science corpus: 8 papers; trusts 11 researchers and is trusted by 59 researchers here, as inferred from the citation graph.

Subfields

Whom Paul Polakis trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

  1. T. Reya
  2. K. Willert
  3. Alexandra Klaus
  4. K. Strebhardt
  5. Marc P. Stemmler
  6. S. Panowski
  7. Hans Clevers
  8. D. Nguyen
  9. F. van Roy
  10. H. Raab

Who trusts Paul Polakis overall

  1. J. Green
  2. F. Cong
  3. Christof Niehrs
  4. S. Sell
  5. Moshe Oren
  6. Liang Schweizer
  7. M. Resh
  8. Hans Clevers
  9. P. Savagner
  10. M. Bienz

Papers from Paul Polakis's perspective

Ordered by how strongly the researchers Paul Polakis trusts endorse each paper. Same corpus, a different order for every researcher.

  1. Arming antibodies: prospects and challenges for immunoconjugates (Nature Biotechnology)
  2. Targeting HER2-positive breast cancer with trastuzumab-DM1, an antibody-cytotoxic drug conjugate. (Cancer Research)
  3. Targeted cancer therapy: conferring specificity to cytotoxic drugs. (Accounts of Chemical Research)
  4. Site-specific conjugation of a cytotoxic drug to an antibody improves the therapeutic index (Nature Biotechnology)
  5. AXIN1 mutations in hepatocellular carcinomas, and growth suppression in cancer cells by virus-mediated transfer of AXIN1 (Nature Genetics)
  6. The many ways of Wnt in cancer. (Current Opinion in Genetics and Development)
  7. Wnt signaling in oncogenesis and embryogenesis--a look outside the nucleus. (Science)
  8. Monoclonal antibody successes in the clinic (Nature Biotechnology)
  9. Conjugation site modulates the in vivo stability and therapeutic activity of antibody-drug conjugates (Nature Biotechnology)
  10. A history of cancer chemotherapy. (Cancer Research)

Their papers